semaglutide approval for mash Novo's Wegovy becomes first GLP-1 drug approved Big news in liver health!

Lipo-B decreases fat deposits and speeds up the metabolism and the natural removal of fat from the human body

These align with anecdotal reports cataloged in systematic reviews of online user experiences

Last year, a study revealed people with diabetes who use the drugs could face double the risk of developing age-related macular degeneration, while reports based on adverse event reporting systems and matched cohort studies have suggested some GLP-1 medications have the potential to cause an eye disorder called non-arteritic anterior ischaemic optic neuropathy

By signing up, you agree to our terms of use and privacy policy